Detalhe da pesquisa
1.
Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis.
Ann Neurol
; 92(6): 1046-1051, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094152
2.
Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner.
Int J Mol Sci
; 23(23)2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499533
3.
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies.
Int J Mol Sci
; 22(14)2021 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34299154
4.
Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD.
Int J Mol Sci
; 22(15)2021 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360690
5.
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
J Neuroinflammation
; 16(1): 167, 2019 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416452
6.
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.
Front Immunol
; 15: 1362629, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680485
7.
Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future.
Front Immunol
; 12: 624685, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33679769
8.
Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review.
Neurol Neuroimmunol Neuroinflamm
; 8(6)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663674
9.
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.
Cells
; 9(12)2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33348629
10.
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.
BMJ Open
; 9(9): e030309, 2019 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501122
11.
Shuttling Tolerogenic Dendritic Cells across the Blood-Brain Barrier In Vitro via the Introduction of De Novo C-C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation.
Front Immunol
; 8: 1964, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29403473
12.
GMP-Grade mRNA Electroporation of Dendritic Cells for Clinical Use.
Methods Mol Biol
; 1428: 139-50, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27236797